Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;14(11):e2404907.
doi: 10.1002/adhm.202404907. Epub 2025 Mar 19.

Monitoring Acidification Preceding Aβ Deposition in Alzheimer's Disease

Affiliations

Monitoring Acidification Preceding Aβ Deposition in Alzheimer's Disease

Guannan Zhu et al. Adv Healthc Mater. 2025 Apr.

Abstract

Amyloid beta (Aβ) is the primary early biomarker of Alzheimer's disease (AD), and since an acidic environment promotes Aβ aggregation, acidification plays a crucial role in AD progression. In this study, a novel acid-responsive near-infrared (NIR) fluorescent probe alongside multiple molecular biology techniques to investigate the temporal relationship between acidification and Aβ deposition, as well as the underlying mechanisms of acidification is employed. By monitoring 2- to 11-month-old APP/PS1 mice and wild-type (WT) mice, it is detected significant fluorescence signal in APP/PS1 mice beginning at 3 months preceding Aβ deposition at 5 months, and peaking at 5 months, followed by cognitive deficits at 8 months. Additionally, elevated monocarboxylate transporter 4 (MCT4) protein expression in 3-month-old APP/PS1 mice indicated disruption of astrocyte-neuron lactate shuttle (ANLS) homeostasis. Overall, this findings first demonstrate that acidification precedes Aβ deposition, peaks at the onset of Aβ deposition, and diminishes thereafter, with early acidification likely driven by the disruption of ANLS.

Keywords: Alzheimer's disease; acid‐responsive; extracellular acidification; monocarboxylate transporter 4; near‐infrared fluorescent probe.

PubMed Disclaimer

References

    1. a) J. Jia, Y. Ning, M. Chen, S. Wang, H. Yang, F. Li, J. Ding, Y. Li, B. Zhao, J. Lyu, S. Yang, X. Yan, Y. Wang, W. Qin, Q. Wang, Y. Li, J. Zhang, F. Liang, Z. Liao, S. Wang, N. Engl. J. Med. 2024, 390, 712;
    1. b) N. J. Ashton, S. Janelidze, N. Mattsson‐Carlgren, A. P. Binette, O. Strandberg, W. S. Brum, T. K. Karikari, F. González‐Ortiz, G. Di Molfetta, F. J. Meda, E. M. Jonaitis, R. L. Koscik, K. Cody, T. J. Betthauser, Y. Li, E. Vanmechelen, S. Palmqvist, E. Stomrud, R. J. Bateman, H. Zetterberg, S. C. Johnson, K. Blennow, O. Hansson, Nat. Med. 2022, 28, 2555.
    1. Z. Qian, Z. Wang, B. Li, X. Meng, Z. Kuang, Y. Li, Y. Yang, K. Ye, Mol. Psychiatry 2024, 29, 3040.
    1. a) L. Vermunt, S. A. M. Sikkes, A. van den Hout, R. Handels, I. Bos, W. M. van der Flier, S. Kern, P. J. Ousset, P. Maruff, I. Skoog, F. R. J. Verhey, Y. Freund‐Levi, M. Tsolaki, K. Wallin Å, M. Olde Rikkert, H. Soininen, L. Spiru, H. Zetterberg, K. Blennow, P. Scheltens, G. Muniz‐Terrera, P. J. Visser, Alzheimers Dement. 2019, 15, 888;
    1. b) A. Gustavsson, N. Norton, T. Fast, L. Frölich, J. Georges, D. Holzapfel, T. Kirabali, P. Krolak‐Salmon, P. M. Rossini, M. T. Ferretti, L. Lanman, A. S. Chadha, W. M. van der Flier, Alzheimers Dement. 2023, 19, 658;

LinkOut - more resources